Wilsey Asset Management Inc Biogen Inc. Transaction History

Wilsey Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$282.99 - $369.05 $6.43 Million - $8.38 Million	-22,708 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $62,937 - $100,774	-243 Reduced 1.06%	22,708 $7.86 Million
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $26,481 - $31,024	109 Added 0.48%	22,951 $6.42 Million
Q4 2020 Feb 19, 2021	BUY	$236.26 - $355.63 $5.4 Million - $8.12 Million	22,842 New	22,842 $5.59 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wilsey Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wilsey Asset Management Inc with notifications on news.